{"pmid":32397512,"title":"The Endless Challenges of Arboviral Diseases in Brazil.","text":["The Endless Challenges of Arboviral Diseases in Brazil.","In this Editorial, we list and discuss some of the main challenges faced by the population and public health authorities in Brazil concerning arbovirus infections, including the occurrence of concurrent epidemics like the ongoing SARS-CoV-2/COVID-19 pandemic.","Trop Med Infect Dis","Magalhaes, Tereza","Chalegre, Karlos Diogo M","Braga, Cynthia","Foy, Brian D","32397512"],"abstract":["In this Editorial, we list and discuss some of the main challenges faced by the population and public health authorities in Brazil concerning arbovirus infections, including the occurrence of concurrent epidemics like the ongoing SARS-CoV-2/COVID-19 pandemic."],"journal":"Trop Med Infect Dis","authors":["Magalhaes, Tereza","Chalegre, Karlos Diogo M","Braga, Cynthia","Foy, Brian D"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32397512","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3390/tropicalmed5020075","keywords":["chikungunya","co-endemic","coronavirus","dengue","zika"],"locations":["Brazil","Brazil"],"countries":["Brazil"],"countries_codes":["BRA|Brazil"],"topics":["Prevention"],"weight":1,"_version_":1666714494718443520,"score":9.490897,"similar":[{"pmid":32462677,"title":"Arboviral diseases and COVID-19 in Brazil: Concerns regarding climatic, sanitation and endemic scenario.","text":["Arboviral diseases and COVID-19 in Brazil: Concerns regarding climatic, sanitation and endemic scenario.","Brazil is witnessing a massive increase of COVID-19 cases and may face some difficulties, not only regarding to other respiratory pathogens, but also to other relevant issues parallelly occurring, for instance, the beggining of autumn and winter seasons, which provides a longer period with high transmissibility of respiratory viroses. Additionally, Brazil is localized in a geographical tropical area with relevant arboviral diseases, where Dengue fever presented highest incidence during March-June, mainly at Southeast and Midwest regions, where probably it will occur overlapping curves of arboviruses and COVID-19, which will overload our public health system. The main affected areas by COVID-19 in Brazil were the same that presented 66% of the Dengue fever cases in Brazil. Moreover, it is importante to highlight the difficulty found to distinguish Dengue fever and COVID-19 and its implications, which present similar laboratorial and clinical characteristics. Besides that, it has been pointed out false-positive results in serological tests for Dengue fever, which later were confirmed as COVID-19. These issues demand urgent attention,once they culminate in serious and devastating impacts in the Brazilian health system, public health, and social conditions. This article is protected by copyright. All rights reserved.","J Med Virol","Ribeiro, Victoria Stadler Tasca","Telles, Joao Paulo","Tuon, Felipe Francisco","32462677"],"abstract":["Brazil is witnessing a massive increase of COVID-19 cases and may face some difficulties, not only regarding to other respiratory pathogens, but also to other relevant issues parallelly occurring, for instance, the beggining of autumn and winter seasons, which provides a longer period with high transmissibility of respiratory viroses. Additionally, Brazil is localized in a geographical tropical area with relevant arboviral diseases, where Dengue fever presented highest incidence during March-June, mainly at Southeast and Midwest regions, where probably it will occur overlapping curves of arboviruses and COVID-19, which will overload our public health system. The main affected areas by COVID-19 in Brazil were the same that presented 66% of the Dengue fever cases in Brazil. Moreover, it is importante to highlight the difficulty found to distinguish Dengue fever and COVID-19 and its implications, which present similar laboratorial and clinical characteristics. Besides that, it has been pointed out false-positive results in serological tests for Dengue fever, which later were confirmed as COVID-19. These issues demand urgent attention,once they culminate in serious and devastating impacts in the Brazilian health system, public health, and social conditions. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Ribeiro, Victoria Stadler Tasca","Telles, Joao Paulo","Tuon, Felipe Francisco"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462677","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26079","keywords":["coronavirus < virus classification","dengue virus < virus classification","endemic infection < epidemiology","influenza virus < virus classification","pandemics < epidemiology","zoonoses < epidemiology"],"locations":["Brazil","Brazil","Dengue","Brazil","Dengue","Brazil","Dengue","Dengue","Brazilian","Brazil"],"countries":["Brazil"],"countries_codes":["BRA|Brazil"],"topics":["Prevention"],"weight":1,"_version_":1668079521457242113,"score":170.36812},{"pmid":32470568,"title":"Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.","text":["Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.","BACKGROUND: Repurposing hydroxychloroquine (HCQ) and chloroquine (CQ) as antiviral agents is a re-emerging topic with new viral epidemics. OBJECTIVES: To summarize evidence from human clinical studies for using HCQ or CQ as antiviral agents for any viral infection. DATA SOURCES: PubMed, EMBASE, Scopus, Web of Science for published studies without time or language restrictions. Cochrane Clinical Trial Registry and Chinese Clinical Trials Registry for trials registered after 2015. MedRxiv for pre-prints within the last 12 months. STUDY ELIGIBILITY CRITERIA: Interventional and prospective observational studies (with or without a control group) PARTICIPANTS: Adults and children with a confirmed viral infection. INTERVENTION: Use of chloroquine or hydroxychloroquine as antiviral agents in one or more groups of the study. METHODS: Two authors independently screened abstracts and all authors agreed on eligible studies. A meta-analysis was planned if similar studies were available in terms of participants, intervention, comparator and outcomes. RESULTS: Nineteen studies were eligible (HIV: 8, HCV: 2, Dengue: 2, Chikungunya: 1, COVID-19: 6) including two pre-prints. Nine and ten studies assessed CQ and HCQ respectively. Benefits of either drug for viral load suppression in HIV is inconsistent. CQ is ineffective in curing dengue (high certainty evidence) and may have little or no benefit in curing chikungunya (low-certainty evidence). The evidence for COVID-19 infection is rapidly evolving but at this stage we are unsure if CQ or HCQ has any benefit in clearing viraemia (very low certainty evidence). CONCLUSIONS: Using HCQ or CQ for HIV/HCV infections is clinically irrelevant now as other effective antivirals are available for viral load suppression (HIV) and cure (HCV). There is no benefit of CQ in dengue and the same conclusion is likely for chikungunya infection. More evidence is needed to confirm if HCQ or CQ is beneficial in COVID-19 infection.","Clin Microbiol Infect","Rodrigo, Chaturaka","Fernando, Sumadhya Deepika","Rajapakse, Senaka","32470568"],"abstract":["BACKGROUND: Repurposing hydroxychloroquine (HCQ) and chloroquine (CQ) as antiviral agents is a re-emerging topic with new viral epidemics. OBJECTIVES: To summarize evidence from human clinical studies for using HCQ or CQ as antiviral agents for any viral infection. DATA SOURCES: PubMed, EMBASE, Scopus, Web of Science for published studies without time or language restrictions. Cochrane Clinical Trial Registry and Chinese Clinical Trials Registry for trials registered after 2015. MedRxiv for pre-prints within the last 12 months. STUDY ELIGIBILITY CRITERIA: Interventional and prospective observational studies (with or without a control group) PARTICIPANTS: Adults and children with a confirmed viral infection. INTERVENTION: Use of chloroquine or hydroxychloroquine as antiviral agents in one or more groups of the study. METHODS: Two authors independently screened abstracts and all authors agreed on eligible studies. A meta-analysis was planned if similar studies were available in terms of participants, intervention, comparator and outcomes. RESULTS: Nineteen studies were eligible (HIV: 8, HCV: 2, Dengue: 2, Chikungunya: 1, COVID-19: 6) including two pre-prints. Nine and ten studies assessed CQ and HCQ respectively. Benefits of either drug for viral load suppression in HIV is inconsistent. CQ is ineffective in curing dengue (high certainty evidence) and may have little or no benefit in curing chikungunya (low-certainty evidence). The evidence for COVID-19 infection is rapidly evolving but at this stage we are unsure if CQ or HCQ has any benefit in clearing viraemia (very low certainty evidence). CONCLUSIONS: Using HCQ or CQ for HIV/HCV infections is clinically irrelevant now as other effective antivirals are available for viral load suppression (HIV) and cure (HCV). There is no benefit of CQ in dengue and the same conclusion is likely for chikungunya infection. More evidence is needed to confirm if HCQ or CQ is beneficial in COVID-19 infection."],"journal":"Clin Microbiol Infect","authors":["Rodrigo, Chaturaka","Fernando, Sumadhya Deepika","Rajapakse, Senaka"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470568","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.cmi.2020.05.016","keywords":["chikungunya","covid-19","dengue","antivirals","chloroquine","hydroxychloroquine","pneumonia"],"locations":["Dengue","Chikungunya"],"topics":["Treatment"],"weight":1,"_version_":1668167110049660928,"score":128.4111},{"pmid":32238177,"pmcid":"PMC7112750","title":"Emerging infectious diseases and outbreaks: implications for women's reproductive health and rights in resource-poor settings.","text":["Emerging infectious diseases and outbreaks: implications for women's reproductive health and rights in resource-poor settings.","This century is witnessing dramatic changes in the health needs of the world's populations. The double burden of infectious and chronic diseases constitutes major causes of morbidity and mortality. Over the last two decades, there has been a rise in infectious diseases, including the severe acute respiratory syndrome virus (SARS), the H1N1 pandemic influenza, the Ebolavirus and the Covid-19 virus. These diseases have rapidly spread across the world and have reminded us of the unprecedented connectivity that defines our modern civilization. Though some countries have made substantial progress toward improving global surveillance for emerging infectious diseases (EIDs), the vast majority of Low-and Middle-income Countries (LMICs) with fragile health systems and various system-related bottlenecks remain vulnerable to outbreaks and, as such, experience dramatic social and economic consequences when they are reported. Lessons learned from past outbreaks suggest that gender inequalities are common across a range of health issues relating to Sexual and Reproductive Health and Rights (SRHR), with women being particularly disadvantaged, partially due to the burden placed on them. Though these countries are striving to improve their health systems and be more inclusive to this vulnerable group, the national/ global outbreaks have burdened the overall system and thus paralyzed normal services dedicated to the delivery of Sexual and Reproductive Health (SRH) services. In this paper, we discuss the global commitments to SRH, the impact of the EIDs on the LMICs, the failure in the delivery of SRH services, and the strategies for successful implementation of recovery plans that must address the specific and differentiated needs of women and girls in resource-poor settings.","Reprod Health","Chattu, Vijay Kumar","Yaya, Sanni","32238177"],"abstract":["This century is witnessing dramatic changes in the health needs of the world's populations. The double burden of infectious and chronic diseases constitutes major causes of morbidity and mortality. Over the last two decades, there has been a rise in infectious diseases, including the severe acute respiratory syndrome virus (SARS), the H1N1 pandemic influenza, the Ebolavirus and the Covid-19 virus. These diseases have rapidly spread across the world and have reminded us of the unprecedented connectivity that defines our modern civilization. Though some countries have made substantial progress toward improving global surveillance for emerging infectious diseases (EIDs), the vast majority of Low-and Middle-income Countries (LMICs) with fragile health systems and various system-related bottlenecks remain vulnerable to outbreaks and, as such, experience dramatic social and economic consequences when they are reported. Lessons learned from past outbreaks suggest that gender inequalities are common across a range of health issues relating to Sexual and Reproductive Health and Rights (SRHR), with women being particularly disadvantaged, partially due to the burden placed on them. Though these countries are striving to improve their health systems and be more inclusive to this vulnerable group, the national/ global outbreaks have burdened the overall system and thus paralyzed normal services dedicated to the delivery of Sexual and Reproductive Health (SRH) services. In this paper, we discuss the global commitments to SRH, the impact of the EIDs on the LMICs, the failure in the delivery of SRH services, and the strategies for successful implementation of recovery plans that must address the specific and differentiated needs of women and girls in resource-poor settings."],"journal":"Reprod Health","authors":["Chattu, Vijay Kumar","Yaya, Sanni"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238177","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1186/s12978-020-0899-y","keywords":["covid-19","ebola","emerging and re-emerging infectious diseases (eids)","gender","low- and middle-income countries (lmics)","sars","sexual and reproductive health and rights (srhrs)","sustainable developmental goals (sdgs)","women","zika"],"locations":["Ebolavirus"],"weight":0,"_version_":1666138490449952768,"score":83.002365},{"pmid":32401828,"title":"The need to strengthen Primary Health Care in Brazil in the context of the COVID-19 pandemic.","text":["The need to strengthen Primary Health Care in Brazil in the context of the COVID-19 pandemic.","The emergence of severe acute respiratory coronavirus 2 (SARS-CoV-2) and its association with severe pneumonia and deaths has exposed gaps in the health systems of several countries worldwide. Although the necessary focus has been to care for hospitalized patients, the strengthening of Primary Health Care (PHC) actions is necessary. PHC is the gateway to the health system in several countries, including Brazil and it plays a role in preventing, protecting, promoting, and treating individuals and communities. Brazil, like other countries, has faced the SARS-CoV-2 pandemic. As Brazil has a universal and decentralized health system, in which PHC has been the model of health re-organizing the health system; here we reflected the importance of strengthening PHC in Brazil in the times of coronavirus disease 2019 pandemic.","Braz Oral Res","Souza, Carlos Dornels Freire de","Gois-Santos, Vanessa Tavares de","Correia, Divanise Suruagy","Martins-Filho, Paulo Ricardo","Santos, Victor Santana","32401828"],"abstract":["The emergence of severe acute respiratory coronavirus 2 (SARS-CoV-2) and its association with severe pneumonia and deaths has exposed gaps in the health systems of several countries worldwide. Although the necessary focus has been to care for hospitalized patients, the strengthening of Primary Health Care (PHC) actions is necessary. PHC is the gateway to the health system in several countries, including Brazil and it plays a role in preventing, protecting, promoting, and treating individuals and communities. Brazil, like other countries, has faced the SARS-CoV-2 pandemic. As Brazil has a universal and decentralized health system, in which PHC has been the model of health re-organizing the health system; here we reflected the importance of strengthening PHC in Brazil in the times of coronavirus disease 2019 pandemic."],"journal":"Braz Oral Res","authors":["Souza, Carlos Dornels Freire de","Gois-Santos, Vanessa Tavares de","Correia, Divanise Suruagy","Martins-Filho, Paulo Ricardo","Santos, Victor Santana"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401828","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1590/1807-3107bor-2020.vol34.0047","locations":["Brazil","Brazil","Brazil","Brazil","Brazil"],"countries":["Brazil"],"countries_codes":["BRA|Brazil"],"topics":["Prevention"],"weight":1,"_version_":1666865855055527936,"score":79.45995},{"pmid":32325980,"title":"Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.","text":["Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.","Emerging and re-emerging viral diseases are of great public health concern. The recent emergence of Severe Acute Respiratory Syndrome (SARS) related coronavirus (SARS-CoV-2) in December 2019 in China, which causes COVID-19 disease in humans, and its current spread to several countries, leading to the first pandemic in history to be caused by a coronavirus, highlights the significance of zoonotic viral diseases. Rift Valley fever, rabies, West Nile, chikungunya, dengue, yellow fever, Crimean-Congo hemorrhagic fever, Ebola, and influenza viruses among many other viruses have been reported from different African countries. The paucity of information, lack of knowledge, limited resources, and climate change, coupled with cultural traditions make the African continent a hotspot for vector-borne and zoonotic viral diseases, which may spread globally. Currently, there is no information available on the status of virus diseases in Africa. This systematic review highlights the available information about viral diseases, including zoonotic and vector-borne diseases, reported in Africa. The findings will help us understand the trend of emerging and re-emerging virus diseases within the African continent. The findings recommend active surveillance of viral diseases and strict implementation of One Health measures in Africa to improve human public health and reduce the possibility of potential pandemics due to zoonotic viruses.","Pathogens","Chauhan, Ravendra P","Dessie, Zelalem G","Noreddin, Ayman","El Zowalaty, Mohamed E","32325980"],"abstract":["Emerging and re-emerging viral diseases are of great public health concern. The recent emergence of Severe Acute Respiratory Syndrome (SARS) related coronavirus (SARS-CoV-2) in December 2019 in China, which causes COVID-19 disease in humans, and its current spread to several countries, leading to the first pandemic in history to be caused by a coronavirus, highlights the significance of zoonotic viral diseases. Rift Valley fever, rabies, West Nile, chikungunya, dengue, yellow fever, Crimean-Congo hemorrhagic fever, Ebola, and influenza viruses among many other viruses have been reported from different African countries. The paucity of information, lack of knowledge, limited resources, and climate change, coupled with cultural traditions make the African continent a hotspot for vector-borne and zoonotic viral diseases, which may spread globally. Currently, there is no information available on the status of virus diseases in Africa. This systematic review highlights the available information about viral diseases, including zoonotic and vector-borne diseases, reported in Africa. The findings will help us understand the trend of emerging and re-emerging virus diseases within the African continent. The findings recommend active surveillance of viral diseases and strict implementation of One Health measures in Africa to improve human public health and reduce the possibility of potential pandemics due to zoonotic viruses."],"journal":"Pathogens","authors":["Chauhan, Ravendra P","Dessie, Zelalem G","Noreddin, Ayman","El Zowalaty, Mohamed E"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32325980","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3390/pathogens9040301","keywords":["africa","covid-19","ebola","rift valley fever virus","sars-cov-2","west nile virus","avian influenza","coronaviruses","dengue","emerging","epidemiology","hemorrhagic fever","infectious diseases","influenza a virus","monkeypox","one health","pandemic","rabies","re-emerging","simian immunodeficiency","vector-borne","virus","zoonosis"],"locations":["China","chikungunya","dengue"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138494648451072,"score":72.430115}]}